Radiopharmaceutical Electroplating Solutions
ProPlate® delivers precision gold plating for cyclotron targets used in radiopharmaceutical production, supporting the consistent, high-purity isotope output that diagnostics and targeted cancer therapy depend on.
What Are Radiopharmaceuticals?
Radiopharmaceuticals are radioactive compounds used in nuclear medicine for diagnostic imaging and targeted cancer therapy. They combine a radioactive isotope with a biologically active molecule that delivers radiation precisely to targeted tissues, enabling non-invasive visualization of organ function and metabolic processes or direct treatment of diseased cells.
The global radiopharmaceutical market is growing rapidly, driven by increasing adoption of PET imaging, expansion of theranostics for oncology, and new isotope supply chain investments. Copper-64 (Cu-64), Gallium-68 (Ga-68), and Lutetium-177 (Lu-177) are among the most clinically significant isotopes in current and emerging radiopharmaceutical applications.
Producing these isotopes reliably and at pharmaceutical-grade purity requires precision manufacturing of the targets and hardware used inside cyclotron systems. Electroplating plays a direct and critical role in that process.
The Role of Electroplating in Radiopharmaceutical Production
Cyclotron-based isotope production relies on solid targets, typically a metal backing plate with an enriched isotope material electrodeposited onto its surface. The quality of that electrodeposited layer directly determines isotope yield, purity, and target longevity.
Gold-plated copper is the most widely used backing material for cyclotron solid targets. Gold is selected for its chemical inertness during the dissolution process that follows proton bombardment, its excellent thermal conductivity for heat dissipation under high-energy irradiation, and its resistance to corrosion from the aggressive chemical environments used in isotope separation.
When bare copper is used without a gold layer, oxidation and surface contamination can introduce impurities into the isotope product, compromising pharmaceutical-grade purity. A uniform, precisely deposited gold layer eliminates this contamination pathway and allows the copper backing to survive multiple production cycles without degradation.
Electroplating in Cu-64 Production
Copper-64 is produced via proton bombardment of enriched Nickel-64 (Ni-64) electrodeposited onto a gold-plated copper target backing. The 64Ni(p,n)64Cu nuclear reaction takes place when the cyclotron beam strikes the nickel layer, generating Cu-64 that is then chemically separated and purified for radiopharmaceutical use.
The gold plating on the copper backing serves three functions in this process. First, it prevents copper ion contamination during target dissolution in hydrochloric acid, which would compromise the molar activity of the final Cu-64 product. Second, it provides a chemically inert surface onto which the enriched Ni-64 can be uniformly electrodeposited. Third, it enables the concave gold backing to function as the reaction vessel during target dissolution, a design approach validated in peer-reviewed production protocols. These functions are consistent with established cyclotron solid target production protocols documented by the International Atomic Energy Agency.
Beam currents in modern cyclotron production systems can exceed 200 µA at proton energies of 15 to 30 MeV. The gold layer and copper substrate must manage significant thermal loads under these conditions while maintaining dimensional and surface integrity across repeated production cycles.
Electroplating in Ga-68 and Other Isotope Production
Similar gold-backed target systems are used in the cyclotron production of Gallium-67 (Ga-67) and Gallium-68 (Ga-68), where zinc isotopes are electrodeposited onto gold or gold-coated aluminum backings and irradiated via the 68Zn(p,2n)67Ga or related reactions. The same electroplating precision requirements apply: uniform thickness, strong adhesion, and chemical resistance throughout the irradiation and dissolution cycle.
Have questions about gold plating specifications for your cyclotron target application? Our experts are ready to help.
ProPlate’s Gold Plating Capabilities for Radiopharmaceutical Targets
ProPlate specializes in advanced gold and selective gold plating for cyclotron targets used in radiopharmaceutical manufacturing. Our processes are engineered to meet the precision, purity, and durability requirements of this demanding application.
Uniform Gold Deposition
ProPlate deposits thick, uniform gold layers onto copper target backings with controlled thickness and surface consistency. Uniformity is critical because uneven gold coverage creates areas of exposed copper that can introduce metallic impurities during the dissolution process, reducing isotope purity and specific activity.
Surface Preparation and Adhesion
Rigorous substrate cleaning and preparation before plating ensures optimal gold adhesion to the copper backing. Poor adhesion can result in gold layer delamination under the thermal stress of high-energy proton bombardment, compromising target integrity and production continuity.
Selective Gold Plating and Custom Fixturing
ProPlate’s in-house CNC machining and custom fixture fabrication capabilities allow precise control over which surfaces receive gold coverage. For cyclotron target geometries that require plating on specific surfaces only, ProPlate’s selective plating methods ensure clean coverage boundaries and minimal material waste.
Controlled Process Parameters
Bath composition, current density, and voltage are meticulously managed throughout the plating process to produce a consistent, durable gold layer. ProPlate’s in-house chemistry lab performs real-time bath analysis and process monitoring, ensuring each target meets specification before it leaves the facility.
Why Target Quality Matters in Radiopharmaceutical Production
In radiopharmaceutical manufacturing, target quality is not a manufacturing preference. It is a pharmaceutical quality requirement. Isotope purity, specific activity, and radionuclidic consistency are all directly influenced by the quality of the target used in production.
Targets that fail prematurely, delaminate under beam current, or introduce metallic contaminants during dissolution can compromise an entire production batch. In a field where isotopes have short half-lives and production schedules are tightly coordinated with clinical demand, unplanned downtime and batch failures have direct consequences for patient care.
Consistent, well-characterized target plating reduces these risks. It supports reproducible production yields, extends target service life across multiple bombardment cycles, and simplifies the dissolution and purification steps that follow irradiation.
ProPlate has documented these outcomes with radiopharmaceutical manufacturing customers. Targets plated to ProPlate’s specifications have demonstrated improved production consistency, reduced isotope shortages through more reliable yield, and lower total cost of ownership through extended target reuse. For a detailed technical review of these outcomes, read here: Advancing Radiopharmaceutical Production with Gold-Plated Copper Targets.
Gold-plated copper targets used in cyclotron-based radiopharmaceutical production required enhanced durability, corrosion resistance, and thermal performance to maintain isotope purity and operational efficiency. ProPlate developed precision gold plating processes with controlled thickness and selective application to withstand high-energy irradiation and harsh chemical environments. The result was improved Cu-64 production yield, extended target lifespan, and reduced downtime for radiopharmaceutical manufacturers.
Ready to discuss target specifications for your production program? Submit a request and our team will follow up.
Related Capabilities and Resources
Gold Plating Services
Precision gold electroplating to ASTM B488, MIL-G-45204, and AMS 2422 specifications
Electroplating Services
Custom engineered electroplating for complex applications and non-standard geometries
Frequently Asked Questions About Radiopharmaceutical Electroplating
What is the role of electroplating in radiopharmaceutical production?
Electroplating is used in two primary ways in radiopharmaceutical production. First, gold is electroplated onto copper target backings to create a chemically inert, thermally conductive surface that protects the copper during proton bombardment and the subsequent acid dissolution process used to separate the isotope. Second, enriched isotope materials such as Nickel-64 or Zinc-68 are electrodeposited onto these gold-backed targets to create the solid target layer that is irradiated in the cyclotron to produce the desired radioisotope.
Why is gold used for cyclotron target backings?
Gold is selected for cyclotron target backings because of its chemical inertness in the acidic dissolution environments used after irradiation, its excellent thermal conductivity for managing heat generated by high-energy proton beams, and its resistance to oxidation and corrosion. A uniform gold layer on the copper backing prevents metallic contamination of the isotope product during dissolution, which is critical for achieving pharmaceutical-grade purity and high specific activity.
What isotopes are produced using gold-plated copper targets?
Gold-plated copper targets are most commonly used in the production of Copper-64 (Cu-64) via the 64Ni(p,n)64Cu reaction, where enriched Nickel-64 is electrodeposited onto the gold-backed copper target and irradiated. Similar gold-backed target systems are used in the production of Gallium-67 and Gallium-68, where zinc isotopes are electrodeposited onto gold or gold-coated backings.
What plating specifications are required for cyclotron targets?
Cyclotron targets require thick, uniform gold deposits with strong adhesion to the copper substrate. The gold layer must maintain integrity under beam currents exceeding 200 µA at proton energies of 15 to 30 MeV and must be chemically resistant to the hydrochloric acid dissolution process used after irradiation. ProPlate provides gold plating to ASTM B488 and customer-specific specifications, with bath chemistry and process parameters controlled to ensure consistent deposition across each target.
Can ProPlate plate cyclotron targets to customer-specific geometries?
Yes. ProPlate’s in-house CNC machining and custom fixture fabrication capabilities allow us to develop plating fixtures and selective coverage configurations for non-standard target geometries. We work with customers to define the required plated surfaces, coverage boundaries, and thickness specifications for each application.
Does ProPlate have experience with radiopharmaceutical manufacturing customers?
Yes. ProPlate has worked with radiopharmaceutical manufacturers and cyclotron operators to develop and supply gold-plated copper targets for isotope production programs. Technical details of our process and customer outcomes are available in our white paper on advancing radiopharmaceutical production with gold-plated copper targets.